Antimicrobial compounds from tropical rainforest plants
dc.contributor.author
Prescott, Thomas Alexander Kyle
en
dc.date.accessioned
2019-02-15T14:17:16Z
dc.date.available
2019-02-15T14:17:16Z
dc.date.issued
2005
dc.description.abstract
en
dc.description.abstract
Tropical rainforest plants represent a potential source of novel antimicrobial drugs since
they have adapted to their humid, septic environment by synthesising such compounds
as a means of self defence. Similarly, people who inhabit rainforests have adopted
certain species to treat infectious diseases, and by investigating such plant medicines it
may be possible to find novel compounds with therapeutic potential. With this is mind,
ethnobotanical fieldwork was carried out in New Guinea, an area of the world little
investigated for indigenous plant medicines and rich in endemic flora. An antibacterial
field assay kit was developed using freeze-dried strains of S. epidermidis and E. coli
which allowed plants used in traditional medicines to be screened in situ without having
to take them back to a
laboratory. This approach identified Lunasia amara (Blanco) as a
candidate species; the use of its bark by tribes of the Whitman Range to treat tropical
ulcers, supported by clear zones of inhibition with S. aureus. Samples of the bark were
collected for analysis and through activity-guided fractionation, the anti- S. aureus
activity of the bark extract was pinned down to a single well resolved HPLC peak (MIC
S. aureus NCTC 6571 64μg/ml) which subsequent NMR analysis revealed to be the
quinoline alkaloid lunacridine; 2'-<9-trifluoroacetyl lunacridine was found to be a more
stable derivative however. Lunacridine's planar cationic structure suggested it might act
as a DNA intercalator; 220μM giving 50% binding in an ethidium bromide displacement
assay. This in turn suggested DNA topoisomerase II as a likely target for the compound
which was confirmed with a kDNA decatenation assay revealing complete inhibition of
the enzyme at 5μM. Cell viability assays with MRC-5, H226 and HELA cells showed
the compound to be cytotoxic in a time dependent manner producing non-linear dose
response curves indicative of a topoisomerase poison mode of action. Activation of the
apoptosis pathway enzymes caspase 3/7 was also detected, reaching maximal activity
between 24 and 48 hours for the H226 cell line. Thus, lunacridine does not represent a
selective antibiotic but with the right structural modifications could be developed as an
antineoplastic agent.
en
dc.identifier.uri
http://hdl.handle.net/1842/33589
dc.publisher
The University of Edinburgh
en
dc.relation.ispartof
Annexe Thesis Digitisation Project 2019 Block 22
en
dc.relation.isreferencedby
Already catalogued
en
dc.title
Antimicrobial compounds from tropical rainforest plants
en
dc.type
Thesis or Dissertation
en
dc.type.qualificationlevel
Doctoral
en
dc.type.qualificationname
PhD Doctor of Philosophy
en
Files
Original bundle
1 - 1 of 1
- Name:
- PrescottTAK_2005redux.pdf
- Size:
- 27.06 MB
- Format:
- Adobe Portable Document Format
This item appears in the following Collection(s)

